Infection Control Surveillance Solutions Market Size, Share, and Trends 2024 to 2034

The global infection control surveillance solutions market size is calculated at USD 950.78 billion in 2025 and is forecasted to reach around USD 3,046.65 billion by 2034, accelerating at a CAGR of 15.40% from 2025 to 2034. The North America infection control surveillance solutions market size surpassed USD 369.77 billion in 2024 and is expanding at a CAGR of 15% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 4345
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infection Control Surveillance Solutions Market 

5.1. COVID-19 Landscape: Infection Control Surveillance Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infection Control Surveillance Solutions Market, By Component

8.1. Infection Control Surveillance Solutions Market, by Component

8.1.1. Software

8.1.1.1. Market Revenue and Forecast

8.1.2. Services

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Infection Control Surveillance Solutions Market, By End-User

9.1. Infection Control Surveillance Solutions Market, by End-User

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast

9.1.3. Specialty Surgical Centers

9.1.3.1. Market Revenue and Forecast

9.1.4. Ambulatory Surgical Centers

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Infection Control Surveillance Solutions Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Component

10.1.2. Market Revenue and Forecast, by End-User

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Component

10.1.3.2. Market Revenue and Forecast, by End-User

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Component

10.1.4.2. Market Revenue and Forecast, by End-User

10.2. Europe

10.2.1. Market Revenue and Forecast, by Component

10.2.2. Market Revenue and Forecast, by End-User

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Component

10.2.3.2. Market Revenue and Forecast, by End-User

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Component

10.2.4.2. Market Revenue and Forecast, by End-User

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Component

10.2.5.2. Market Revenue and Forecast, by End-User

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Component

10.2.6.2. Market Revenue and Forecast, by End-User

10.3. APAC

10.3.1. Market Revenue and Forecast, by Component

10.3.2. Market Revenue and Forecast, by End-User

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Component

10.3.3.2. Market Revenue and Forecast, by End-User

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Component

10.3.4.2. Market Revenue and Forecast, by End-User

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Component

10.3.5.2. Market Revenue and Forecast, by End-User

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Component

10.3.6.2. Market Revenue and Forecast, by End-User

10.4. MEA

10.4.1. Market Revenue and Forecast, by Component

10.4.2. Market Revenue and Forecast, by End-User

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Component

10.4.3.2. Market Revenue and Forecast, by End-User

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Component

10.4.4.2. Market Revenue and Forecast, by End-User

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Component

10.4.5.2. Market Revenue and Forecast, by End-User

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Component

10.4.6.2. Market Revenue and Forecast, by End-User

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Component

10.5.2. Market Revenue and Forecast, by End-User

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Component

10.5.3.2. Market Revenue and Forecast, by End-User

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Component

10.5.4.2. Market Revenue and Forecast, by End-User

Chapter 11. Company Profiles

11.1. Becton

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Dickinson and Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Premier Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Wolters Kluwer N.V

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Gojo Industries

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. RL Solutions

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Baxter International Inc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Premier Inc.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Truven Health Analytics (An IBM Company)

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global infection control surveillance solutions market size is expected to increase USD 3,046.65 million by 2034 from USD 839.98 million in 2024.

The global infection control surveillance solutions market will register growth rate of 15.40% between 2025 and 2034.

The major players operating in the infection control surveillance solutions market are Becton, Dickinson and Company, Premier Inc., Wolters Kluwer N.V, Gojo Industries, RL Solutions, Baxter International Inc., Premier Inc., Truven Health Analytics (An IBM Company), and Others.

The driving factors of the infection control surveillance solutions market are the increasing advancements for hospital safety and rising investments in research and development activities.

North America region will lead the global infection control surveillance solutions market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client